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Introduction
The therapeutic procedure of endoscopic retrograde cholan-
giopancreatography (ERCP) of pancreaticobiliary disease is safe 
and effective [1]. Biliary and pancreatic diseases are frequently 
associated with complications in the elderly and are therefore 
attracting more attention owing to the increasing elderly popula-
tion [2,3]. Several studies have been conducted on the safety 
and efficacy of therapeutic ERCP for elderly patients [4-6]. 
However, there is concern about the risk of cardiopulmonary 
complications and mortality in elderly patients who undergo 
ERCP, especially when they are sedated during the procedure 
[7,8]. Studies on the safety and efficacy of sedative ERCP in 
elderly patients have predominantly been conducted in Western 
populations [9,10]. Only a few prospective studies have been 
reported on elderly Asian patients [6,7]. The aim of our study 
was to evaluate the safety and efficacy of midazolam induced 
sedative ERCP in elderly patients and also conducted small study 
of unsedated ERCP in elderly. Seventy patients were enrolled 
and therapeutic ERCP was performed with or without sedation. 
Methods
1. Subjects
Seventy patients older than 70 years were enrolled and di-
vided into two groups. A single blind randomized allocation was 
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Objectives: The purpose of this study was to compare the safety and efficacy of 
midazolam sedated Endoscopic retrograde cholangiopancreatography (ERCP) with 
unsedated ERCP in patients 70 years of ages and older.
Methods: Seventy elderly patients 70 years of age or older who underwent ERCP 
were divided into two groups: midazolam sedated group (n=43) and unsedated group 
(n=27). Procedure time, success rate, complications related with ERCP procedure, sat-
isfaction score were analyzed between two groups. 
Results: Mean procedure time was 20.6 minutes for sedated group and 21.0 minutes 
for unsedated group (P=0.88). Success rate was 87.5% for sedated group and 100% for 
unsedated group (P=0.07). Incidence of complications from ERCP procedure showed no 
significant differences between the sedated and unsedated groups (P=0.10). There was no 
mortality in both groups related to the sedation or post-ERCP complication. Compared 
to the unsedated procedure, the sedated ERCP procedure was associated with higher pa-
tient satisfaction (P<0.001) and better repeat compliance (P=0.004). 
Conclusion:  There was no significant difference in success rate and complications 
at sedated and unsedated ERCP in patients 70 years of age and older. Unsedated 
ERCP showed 66.6% satisfaction score compared to sedated ERCP. (Ewha Med J 
2014;37(2):92-97)
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employed. The allocation sequence was concealed, and patients 
were assigned allocation on the day of ERCP procedure. ERCP 
procedures were performed by an experienced endoscopist at 
the Ewha Womans University Mokdong Hospital, Seoul, Korea. 
Written informed consent was obtained from each patient. Pa-
tients who refused the allocation were excluded from the study. 
All date from the study were stored on an encrypted server, and 
passwords were required to log in.
Overall, 70 patients were enrolled the study. Forty-three 
patients were allocated to midazolam induced sedated ERCP 
group, and 27 patients were allocated to unsedated ERCP group. 
We analyzed underlying diseases and past medical history, 
including pancreatitis, previous cholecystectomy, and medica-
tions such as antiplatelet agents. ERCP findings, success rate, 
procedure duration, adverse events during ERCP (hypoxemia, 
electrocardiogram change, and hypotension), procedure-related 
complications (pancreatitis, bleeding, and perforation), and 
mortality within 1 month were evaluated. 
2. ERCP procedure and monitoring
The subjects fasted for at least 8 hours before the ERCP. A 
standard ERCP was performed with the subjects in the lateral 
decubitus position, using an Olympus side-viewing video duo-
denoscope (Olympus TGF240; Olympus Optical Co, Tokyo, 
Japan). The patients were sedated by intravenous administra-
tion of 0.06 mg/kg of midazolam (Dormicum; Roche Korea, 
Seoul, Korea) before the procedure. To reduce duodenal motility 
and secretion, 10 mg of cimetropium bromide was adminis-
tered intravenously. For pain control, 50 mg of meperidine was 
administered intramuscularly before the procedure. Monitoring 
included continuous assessment of peripheral oxygen saturation 
(SpO2), heart rate, and blood pressure. Continuous oxygen ad-
ministration was not used during sedation. When the SpO2 was 
less than 90%, oxygen was provided and an antidote for mid-
azolam, flumazenil (Anexate; Roche Korea) was injected. 
Hypoxemia was defined as a SpO2 level of less than 90% for 
at least 10 seconds. Troponin T (TnT) elevation was defined as 
an increase in TnT level of at least 0.01 ng/mL. An electrocar-
diogram (ECG) change was defined as a new downward slope 
or horizontal elevation of the ST segment, an ECG decrease 
of 0.1 mV or more, or an ST segment elevation of 0.2 mV 
or more above baseline for at least 1 minute. Tachycardia was 
defined as heart rate in excess of 100 beats per minute (bpm), 
bradycardia as heart rate of less than 50 bpm, and hyperten-
sion as systemic blood pressure greater than 200 mmHg. Hy-
potension was defined as systemic blood pressure less than 80 
mmHg. Post-ERCP pancreatitis was defined as significant per-
sistent (≥24 hours) abdominal pain associated with an elevation 
in amylase or lipase by at least 3 times above the upper limit of 
normal. After the procedure, vital signs and laboratory findings, 
including TnT levels, were noted. Morbidity and mortality were 
recorded for 30 days after the ERCP procedure.
3. Satisfaction score
A 10-point visual analogue scale was used to estimate the 
tolerance and satisfaction levels of patients on the day after the 
procedure. A score of 0 indicated a very poor satisfaction level, 
and a score of 10 indicated a very high one. Compliance with 
the procedure was assessed according to whether the patient 
would agree to a repetition of the same procedure, should the 
need arise. 
4. Statistical analysis
The SAS ver. 9.1 (SAS Institute Inc., Cary, NC, USA) was 
used for statistical analysis. Data are expressed as the mean and 
standard deviation. Statistical analysis was performed using the 
Student t test. Logistic regression analysis was performed be-
tween complication and sedation and between complication and 
procedure time over 30 minutes. A two-tailed P value<0.05 
was considered statistically significant.
Results
1. General characteristics and clinical presentations
The demographic and clinical characteristics of subjects in 
the two study groups were compared. There were no statistically 
significant differences in age, sex, weight, height, or smoking 
habits between two groups (Table 1). 
The difference in the incidence of comorbid disease between 
groups was not significant. The most common comorbidity was 
hypertension, followed by diabetes mellitus, pulmonary diseases 
(such as asthma and chronic obstructive pulmonary disease), 
and cardiovascular diseases (such as coronary artery disease and 
congestive heart failure). There were no significant differences 
between previous history of pancreatitis, cholecystectomy, or 
medication between groups.
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The most common clinical presentation at admission in 
both groups was right upper-quadrant pain. The most com-
mon indication for ERCP was choledocholithiasis in both 
groups (Table 2).
　
2. ERCP results
The mean dosage of midazolam used for sedation in sedated 
group was 3.5±0.8 mg. The duration of the ERCP procedure 
ranged from 5 to 67 minutes, and the mean duration of the 
procedure did not differ between groups (20.6±9.3 minutes vs. 
21.1±11.7 minutes; P=0.88) (Table 3). The success rate was 
88.4% for sedated group and 100% for unsedated group, but 
this difference was not significant (P=0.07). Failure was seen 
on three patients with cannulation failure due to large diver-
ticulum, two patients with clearance failure due to multiple and 
large stones. The most common ERCP finding in both groups 
was a common bile duct stones (88.4% vs. 81.5%).
　
3. ERCP complications
There were no significant cardiopulmonary events, including 
ECG changes, hypoxemia, and hypotension in both groups dur-
ing the ERCP procedure (P=0.62) (Table 4).
No significant differences between number of complications 
that occurred after ERCP were seen (P=0.10). These consisted 
of 4 cases of transient pancreatitis, 2 cases of perforation and 
1 case of bleeding in sedated group, and 1 case of pancreatitis 
after ERCP in unsedated group. 
Two cases of perforation were seen; 70 year-old male patient 
after ampullectomy of ampulla of vater adenoma with severe 
dysplasia and 87 year-old male patient after removal fail of im-
pacted CBD stone. ERCP time of two cases of perforation were 
38 minutes and 30 minutes, respectively. One case of bleed-
ing was seen in 76 year-old male patient after advanced EST 
for removal of CBD stone. In bleeding case, ERCP time was 15 
minutes. 
Minor complications consisted of ECG changes without TnT 
Table 1. Demographic and clinical data of study participants who 
underwent ERCP under sedation or without sedation 
Variable
Sedated  
group (n=43)
Unsedated 
group (n=27)
Difference 
(P value)
Gender (male:female)    20:23 12:15 0.87
Mean age (yr)    77.5±5.0 77.4±4.8 0.99
Mean weight (kg)    54.8±7.6   57.6±10.3 0.19
Smoking status
   Current smoking
   Smoked in past
   Never smoked
  2
14
27
  0
  6
21
0.63
Hypertension 23 14 0.90
Diabetes mellitus   9   8 0.43
Chronic renal disease   3   1 0.55
Pulmonary disease   7   4 0.87
Cardiovascular disease   8   2 0.16
Cerebral vascular accident    2   4 0.19
Previous pancreatitis   1   2 0.37
Previous ERCP   4   0 0.11
Cholecystectomy 11   5 0.49
Antiplatelet agent 15   6 0.25
ERCP, endoscopic retrograde cholangiopancreatography.
Table 2. Comparison between indications for ERCP in sedated group-
and unsedated group (P=0.87) 
Variable
Sedated  
group (%)
Unsedated  
group (%)
Choledocholithiasis 34 (79.1) 22 (81.5)
Bile duct stenosis 1 (2.3) 1 (3.7)
Papillary tumor of pancreas  5 (11.6) 2 (7.4)
AUPBD  3 (7.0) 2 (7.4)
ERCP, endoscopic retrograde cholangiopancreatography; AUPBD, 
anomalous union of pancreaticobiliary duct.
Table 3. Comparison between ERCP results of sedated group and 
unsedated group 
Variable
Sedated  
group (%)
Unsedated  
group (%)
Difference  
(P value)
Success rate 38 (88.4) 27 (100) 0.07
ERCP time (min)* 20.6±9.3 21.0±11.7 0.88
ERCP results
  CBD stone 
  Bile duct dilation† 
  Biliary malignancy 
  IPMN 
38 (88.4)
2 (4.6)
1 (2.3)
2 (4.7)
22 (81.5)
4 (14.8)
0
1 (3.7)
0.87
Diverticulum 22 (51.2) 17 (63.0) 0.34
EST 32 (74.4) 25 (92.6) 0.06
ERCP, endoscopic retrograde cholangiopancreatography; CBD, 
common bile duct; IPMN, intraductal papillary mucinous neoplasm; 
EST, endoscopic sphincterotomy.
*ERCP time expressed as mean±SD values. †Bile duct dilation without 
apparent cause.
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elevation in 3 patients and transient pleural effusions in 2 pa-
tients. There were 2 cases of TnT level elevation without ECG 
change (1 for sedated group, 1 for unsedated group) and there 
were no significant differences between two groups (P=0.65). 
Minor complications were clinically insignificant. No mortali-
ties occurred within a month of the procedure in both groups. 
The logistic regression analysis showed no significance between 
complication and sedation (P=0.14) and between complication 
and procedure time over 30 minutes (P=0.78).
4. Satisfaction score
The satisfaction score was greater in sedated group than 
unsedated group (7.9±1.8 vs. 5.6±2.8; P<0.001), as was 
the compliance for a repeat procedure (90.7% vs. 63.0%; 
P=0.004) (Table 5). Unsedated ERCP showed relatively 66.6% 
satisfaction score if sedated ERCP satisfaction score was 100%. 
Discussion
ERCP is an effective endoscopic procedure for the treatment 
of biliary and pancreatic diseases [1]. There is concern about 
using ERCP for elderly patients because of possible cardiopul-
monary complications [11]. Despite this concern, the demand for 
ERCP in elderly patients is increasing because of the increasing 
incidence of biliary tract disease [2,11]. As the population ages, 
the use of therapeutic endoscopic procedures for treatment of 
the elderly will increase [2,12]. Even when biliary drainage is 
successful in elderly patients, they still exhibit a high incidence 
of severe cholangitis and additional medical complications (such 
as hypotension, altered sensorium, and renal failure), and the 
mortality rate is 9.6% [13]. Transient myocardial ischemia and 
various cardiac arrhythmias frequently occur in elderly patients 
during ERCP [14,15].
Sedation is a critical issue for elderly patients. Most studies 
on sedation have compared its effects in elderly and younger 
patients by using retrospective experimental designs [3,11]. Few 
prospective studies have been performed to examine the risk of 
sedation in the elderly in terms of their tolerance of ERCP pro-
cedures [16-18]. Sedation regimens for ERCP are midazolam 
alone or midazolam plus opioids, propofol alone or balanced 
propofol sedation (propofol in combination with midazolam 
and meperidine) [19]. The midazolam sedation used had been 
previously shown to result in a good level of satisfaction, few 
paradoxical responses, and a short discharge time without any 
side effects [20].
Arterial hypoxemia, arrhythmias, and myocardial ischemia 
have been associated with ERCP in elderly patients [10,11]. Pa-
tients undergoing ERCP may develop true myocardial ischemia 
with reduced myocardial blood flow [18]. Elevated cardio-
specific troponin levels have been presented as biochemical evi-
dence of ERCP-related myocardial injury [11]. Troponin levels 
in patients over 65 years of age become elevated if the duration 
of ERCP exceeds 30 minutes [11]. In the present study, the 
mean procedure time was approximately 20 minutes, and the 
TnT level after ERCP did not differ significantly in both sedated 
and unsedated groups. And the linear regression analysis showed 
no significance between major complication and procedure time 
over 30 minutes. Changes in ECG and TnT levels after ERCP in 
this study were transient and not clinically significant.
Elderly patients who undergo ERCP may be at risk of cardio-
Table 4. Comparison between the number of complications in 
sedated group and unsedated group 
Variable
Sedate 
group (%)
Unsedated 
group (%)
Difference  
(P value)
During ERCP 
  Hypoxemia
  ECG change
  Hypotension
  No complication
2 (4.7)
1 (2.3)
0
40 (93.0)
0
1 (3.7)
1 (3.7)
25 (92.6)
0.62
After ERCP
  Pancreatitis
  Bleeding
  Perforation
  No complication
4 (9.3)
1 (2.3)
2 (4.7)
36 (88.7)
1 (3.7)
0
0
26 (96.3)
0.10
ERCP, endoscopic retrograde cholangiopancreatography; ECG, 
electrocardiogram.
Table 5. Comparison between participant satisfaction level by visual 
analogue score and compliance of sedated group and unsedated 
group 
Variable
Sedated 
 group
Unsedated  
group
Difference  
(P value)
Satisfaction score* 7.9±1.8 5.6±2.7 <0.001
Repeat compliance (%) 90.7 63.0 0.004
*Score on a scale of 1 to 10 points (1, very poor satisfaction; 10, very 
high satisfaction).  mean±SD
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pulmonary complications because of preexisting cardiovascular 
disease, combinations of benzodiazepine and opioid sedation, or 
prolonged procedures [11,21]. Several studies have recently been 
conducted on ERCP in elderly Asian patients. Sugiyama et al. 
[22] showed that ERCP and sphincterotomy are safe treatments 
for choledocholithiasis in people aged above 90 years. Between 
2% and 9% of elderly patients require ventilatory support af-
ter endoscopic sphincterotomy for bile duct stones [22]. The 
most common complications of ERCP in elderly Asian patients 
were cholangitis, pancreatitis, and biliary perforation [22]. The 
complication rate associated with therapeutic ERCP in elderly 
patients was 2.6% according to a prospective study, and short-
term complications after endoscopic sphincterotomy were not 
related to age [23]. 
Of the previously reported prospective studies, only 3 ad-
dressed sedation and age [16-18,20]. Moreover, most prospec-
tive studies were conducted on Western patients. The prospec-
tive studies for Asian patients concerned propofol sedation [6,7] 
or endoscopic sphincterotomy for elderly patients [23].
In the present study, in addition to a higher satisfaction score 
in the sedated group (P<0.001), procedure tolerance or repeat 
compliance was also higher in the sedated group (P=0.004). 
The complications were not significant in both groups, and there 
was no mortality in this study. A limitation of our study is the 
restricted study population, which may be responsible for the dif-
ferences in certain observations of this study compared to those 
of other studies. For instance, there was a relatively low inci-
dence of malignancies and mortality in our subject population.
In conclusion, sedated ERCP is a safe and effective procedure 
for elderly patients aged 70 years and above. Moreover, patients 
who underwent sedated ERCP were more satisfied and had bet-
ter compliance than those treated with nonsedative ERCP. 
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